Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac493 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Tong Yu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Minhang Hospital and Institutes of Biomedical Sciences and Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China Grant, National Grand Program on Key Infectious Disease Control, Shanghai Municipal Science and Technology Committee.
Abstract (Originalsprache)
Background
Chronic hepatitis B is usually treated with nucleos(t)ide analogues (NAs). However, a cure is rarely achieved, even with years of treatment. Here, we investigated whether viral replication is completely halted and how long covalently closed circular DNA (cccDNA) persists in patients successfully treated with NAs.
Methods
A series of longitudinal serum samples and a collection of cross-sectional liver biopsies were obtained from patients successfully treated with NAs. Viral variants in serum HBV RNA were enumerated by deep sequencing. Viral replication intermediates in hepatocytes were directly visualized by in situ hybridization. The apparent half-life of each cccDNA was estimated.
Results
Three of 6 successfully treated patients demonstrated clear evidence of a small proportion of virus evolution, although the overwhelming proportion of variants were identical or possessed a similar degree of divergence through time. The apparent half-life of variants was estimated to be from approximately 7.42 weeks to infinite. Hepatocytes remained positive for cytoplasmic nucleocapsids-associated relaxed circular DNA in 4 of 7 liver needle biopsies.
Conclusions
We conclude that even after prolonged treatment, a small proportion of the cccDNA reservoir is constantly replenished by continued low-level HBV replication, whereas a large proportion of the cccDNA reservoir persists over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Minhang Hospital and Institutes of Biomedical Sciences and Huashan Hospital, Fudan University, Shanghai, China.
- Department of Infectious Disease, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
- Clinical Research Center for Infectious Disease of Hebei Province, Shijiazhuang, China.
- Department of Infectious Disease, Yancheng Second People's Hospital, Yancheng, China.
- Department of Infectious Disease, Jingan District Central Hospital of Shanghai, Shanghai, China.
ORCID-Profile: Jiming Zhang, Zhefeng Meng
Förderung
- National Natural Science Foundation of China Grant
- National Grand Program on Key Infectious Disease Control
- Shanghai Municipal Science and Technology Committee
Zitieren
APA
Yu, T., Zhang, M., Zhang, H., Zheng, J., Shen, C., Jiang, N., Zou, L., Wang, J., Yu, Y., Zhang, Q., Yu, S., Huang, Y., Huang, Y., Zhang, J., Qiu, C., Zhang, W., & Meng, Z. (2023). Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac493
Vancouver
Yu T, Zhang M, Zhang H, Zheng J, Shen C, Jiang N, et al. Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac493
BibTeX
@article{Yu2023,
author = {Yu, Tong and Zhang, Miaoqu and Zhang, Hanyue and Zheng, Jianming and Shen, Chuan and Jiang, Ning and Zou, Lei and Wang, Jing and Yu, Yiqi and Zhang, Qiran and Yu, Shuili and Huang, Yanfang and Huang, Yuxian and Zhang, Jiming and Qiu, Chao and Zhang, Wenhong and Meng, Zhefeng},
title = {Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac493}
}
EUVIMED